{"id":"meprotixol","rwe":[{"pmid":"4595469","year":"1974","title":"[Meprotixol (N 7020). Clinical experiences in rheumatic diseases].","finding":"","journal":"Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke","studyType":"Clinical Study"},{"pmid":"4595468","year":"1974","title":"[Meprotixol (N 7020). Studied in rheumatic diseases in a double blind multicenter investigation in general practice].","finding":"","journal":"Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke","studyType":"Clinical Study"},{"pmid":"4595467","year":"1974","title":"[Clinical trial of a new drug, Meprotixol, with double blind crossover technic with effective compound and placebo. A research project in general practice. General notice].","finding":"","journal":"Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke","studyType":"Clinical Study"},{"pmid":"4913199","year":"1970","title":"[Meprotixol--a new antirheumatic drug].","finding":"","journal":"Nordisk medicin","studyType":"Clinical Study"},{"pmid":"6012748","year":"1966","title":"Pharmacology of a new antitussive agent: meprotixol (N 7020).","finding":"","journal":"Acta pharmacologica et toxicologica","studyType":"Clinical Study"}],"tags":[{"label":"meprotixol","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"R05DB22","category":"atc"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"meprothixol","offLabel":[],"synonyms":["meprotixol","meprothixol"],"timeline":[],"approvals":[],"brandName":"Meprothixol","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"meprotixol","explanation":"Imagine your body's cells have locks on them, and meprothixol is a key that fits into one of those locks. When it binds to the lock, it can either turn the lock open or closed, depending on the type of lock and the key's shape. However, since meprothixol's target is unknown, we can't say exactly how it works or what kind of lock it fits into.","oneSentence":"Meprothixol is a small molecule that works by interacting with a specific target in the body, but its exact mechanism is unknown.","technicalDetail":"Meprothixol's mechanism of action is likely to involve binding to a specific receptor or enzyme, but the exact molecular details are unclear due to a lack of research and data."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4656","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=MEPROTIXOL","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T14:19:36.374064","biosimilars":[],"competitors":[{"drugName":"benzonatate","drugSlug":"benzonatate","fdaApproval":"1958-02-10","genericCount":13,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"pentoxyverine","drugSlug":"pentoxyverine","fdaApproval":"","relationship":"same-class"},{"drugName":"clofedanol","drugSlug":"clofedanol","fdaApproval":"","relationship":"same-class"}],"genericName":"meprotixol","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"benzonatate","brandName":"benzonatate","genericName":"benzonatate","approvalYear":"1958","relationship":"same-class"},{"drugId":"pentoxyverine","brandName":"pentoxyverine","genericName":"pentoxyverine","approvalYear":"","relationship":"same-class"},{"drugId":"clofedanol","brandName":"clofedanol","genericName":"clofedanol","approvalYear":"","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"2JXZ154Z0Q","CHEBI":"CHEBI:134748","INN_ID":"1569","UMLSCUI":"C2981321","ChEMBL_ID":"CHEMBL2105167","KEGG_DRUG":"D07394","DRUGBANK_ID":"DB13822","PUBCHEM_CID":"71195"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":6,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"R05DB22","allCodes":["R05DB22"]},"biosimilarFilings":[],"recentPublications":[{"date":"1974 Feb 10","pmid":"4595469","title":"[Meprotixol (N 7020). Clinical experiences in rheumatic diseases].","journal":"Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke"},{"date":"1974 Feb 10","pmid":"4595468","title":"[Meprotixol (N 7020). Studied in rheumatic diseases in a double blind multicenter investigation in general practice].","journal":"Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke"},{"date":"1974 Feb 10","pmid":"4595467","title":"[Clinical trial of a new drug, Meprotixol, with double blind crossover technic with effective compound and placebo. A research project in general practice. General notice].","journal":"Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke"},{"date":"1970","pmid":"4913199","title":"[Meprotixol--a new antirheumatic drug].","journal":"Nordisk medicin"},{"date":"1966","pmid":"6012748","title":"Pharmacology of a new antitussive agent: meprotixol (N 7020).","journal":"Acta pharmacologica et toxicologica"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Meprothixol is a small molecule drug of the meprotixol class, but its target and mechanism of action are unknown. Its commercial status, including FDA approval and patent status, is also unclear. As a result, there is limited information available on its approved indications, half-life, bioavailability, and generic manufacturers. Further research is needed to understand the clinical utility and safety profile of meprothixol. Its development and ownership history are also unclear.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}